"This is a significant milepost in our journey of serving 5 million patients by FY22 and crossing a revenue milestone of $1 billion," said Christiane Hamacher, CEO, Biocon Biologics.
Subscribe to:
Post Comments (Atom)
-
Thirteen tier 2 and 3 cities register higher traffic in December than pre-COVID-19 levels.
-
Market-men said the fall in gold prices at futures trade was mostly due to trimming of positions by participants.
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
No comments:
Post a Comment